Clinical Trial Update: Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating toripalimab with docetaxel or nab-paclitaxel in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Nab-paclitaxel (paclitaxel protein-bound)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Tao Zhang | Conditions: Gastric Cancer Stage IV | Phase 2 | Status: UNKNOWN